AGREEMENT REGARDING REGORAFENIB between BAYER HEALTHCARE LLC and ONYX PHARMACEUTICALS, INC. Dated as of October 11, 2011Agreement Regarding Regorafenib • February 27th, 2012 • Onyx Pharmaceuticals Inc • Biological products, (no disgnostic substances) • California
Contract Type FiledFebruary 27th, 2012 Company Industry JurisdictionThis AGREEMENT REGARDING REGORAFENIB (this “Agreement”) is entered into as of this 11th day of October, 2011 (the “Effective Date”) between BAYER HEALTHCARE LLC, a Delaware limited liability company (“Bayer”) and ONYX PHARMACEUTICALS, INC., a Delaware corporation (“Onyx”). Bayer and Onyx are sometimes referred to herein individually as a “Party” and collectively as the “Parties.”